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Abstract
Background: To assess the influence of the crestal or subcrestal placement of implants upon peri-implant bone loss 
over 12 months of follow-up.
Material and Methods: Twenty-six patients with a single hopeless tooth were recruited in the Oral Surgery 
Unit (Valencia University, Valencia, Spain). The patients were randomized into two treatment groups: group A 
(implants placed at crestal level) or group B (implants placed at subcrestal level). Control visits were conducted by 
a trained clinician at the time of implant placement and 12 months after loading. A previously established standard 
protocol was used to compile general data on all patients (sex and age, implant length and diameter, and brushing 
frequency). Implant success rate, peri-implant bone loss and the treatment of the exposed implant surface were 
studied. The level of statistical significance was defined as 5% (α=0.05).
Results: Twenty-three patients (8 males and 15 females, mean age 49.8±11.6 years, range 28-75 years) were 
included in the final data analyses, while three were excluded. All the included subjects were non-smokers with 
a brushing frequency of up to twice a day in 85.7% of the cases. The 23 implants comprised 10 crestal implants 
and 13 subcrestal implants. After implant placement, the mean bone position with respect to the implant platform 
in group A was 0.0 mm versus 2.16±0.88 mm in group B. After 12 months of follow-up, the mean bone positions 
were -0.06±1.11 mm and 0.95±1.50 mm, respectively - this representing a bone loss of 0.06±1.11 mm in the case of 
the crestal implants and of 1.22±1.06 mm in the case of the subcrestal implants (p=0.014). Four crestal implants 
and 5 subcrestal implants presented peri-implant bone levels below the platform, leaving a mean exposed treated 
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surface of 1.13 mm and 0.57 mm, respectively. The implant osseointegration success rate at 12 months was 100% in 
both groups.
Conclusions: Within the limitations of this study, bone loss was found to be greater in the case of the subcrestal 
implants, though from the clinical perspective these implants presented bone levels above the implant platform after 
12 months of follow-up.
Key words: Immediate implants, tooth extraction, dental implants, single-tooth, crestal bone, placement level.
Introduction
The connecting line between implant and abutment, 
the so-called microgap, has been intensely investigated 
during the last 10 years. This microgap has been cited 
as one of the factors capable of influencing peri-implant 
bone resorption in conjunction with other factors such 
as surgical trauma, the establishment of biological 
width, implant design and implant positioning (1-3). 
The preservation of peri-implant bone is an important 
factor for success. The quantity and quality of the bone 
surrounding an implant affects implant osseointegration, 
influences the shape and contour of the overlying soft 
tissues, which are important for the esthetic outcome of 
treatment (4), and it has been reported that if an implant 
with a rough surface is exposed to the oral cavity, a 
greater amount of plaque, leading to perimucositis and 
peri-implantitis, may be present (5). The occurrence of 
peri-implantitis around implants with roughened surfaces 
is likely to be even higher, since it was observed that 
statistically significantly more peri-implantitis occurred 
at 3 years of loading around implants with roughened 
surfaces when compared to turned implants (6).
Branemark et al. (7) recommended surgical implant 
countersinking below the bone crest, which prevents 
implant exposure during bone remodeling. Well-
documented long-term clinical studies with these 
systems have also revealed highly predictable outcomes 
(8-10). In contrast, several studies have shown the 
absence of a microgap at or below the alveolar crest level 
in non-submerged implant systems to result in less peri-
implant marginal bone loss than with submerged implant 
systems (11,12). Furthermore, apical positioning of the 
implants did not influence ridge loss or the position of 
the peri-implant soft tissue margin (13). On the other 
hand, subcrestal implant placement has recently been 
associated to increased marginal bone loss (14), and 
Hammerle et al. had already concluded that such an 
approach was not to be recommended (9).
Such increased loss may be caused by bacterial 
colonization of the microgap present in the fixture-
abutment junction (15). The inside of the connection 
has a low oxygen concentration and is away from the 
inflammatory defensive response of the peri-implant 
tissues, so it is an ideal environment for anaerobic 
bacteria (16). The potential colonization through the 
micro-gap is related to multifactorial conditions, 
including the precision fit between the components 
which is associated with the implant system design. A 
recent systematic review (17) claimed the superiority 
of conical connections in seal performance, microgap 
formation, torque maintenance and abutment stability.
The aim of this study was to assess the influence of the 
crestal or subcrestal placement of implants upon peri-
implant bone loss over 12 months of follow-up.
Material and Methods
- Patient screening and recruitment
Patients with a single hopeless tooth were recruited (Oral 
Surgery Unit, Valencia University, Valencia, Spain). 
The research was performed following the principles 
of the Declaration of Helsinki on research involving 
human beings and the study design was approved by 
the ethical review board of the University of Valencia 
(Ref: H1365580155510). Table 1 specifies the inclusion 
and exclusion criteria. Patients who met the criteria 
and agreed to participate in the study were asked to 
read, understand, ask questions, and sign an informed 
consent form. The study was conducted from December 
2012 to August 2014.
- Preoperative procedure
Upper and lower alginate impressions were taken from 
each patient for planning and fabricating measurement 
stents and surgical guides, all patients received rigorous 
oral hygiene and were given instructions for improving 
and maintaining oral hygiene at home. Extraction of 
teeth was done with great care; in the case of multiple 
root teeth, dental sectioning was performed and the 
roots were extracted separately, respecting the alveolar 
walls (especially the vestibular wall). The patients 
were instructed to wear a removable, tooth-supported 
provisional prosthesis during the healing phase (only in 
the esthetic zone).
After three months of tooth socket healing, each patient 
was randomized to one of two treatment regimens: 
group A (all implants were placed at crestal level) (Fig. 
1) or group B (all implants were placed at subcrestal 
level)  (Fig. 2). Random assignment was performed by a 
professional statistician using pre-defined randomization 
tables. A balanced random permuted-block approach 
was used to prepare the randomization tables in order 
to avoid unequal balance between the two treatment 
groups. 
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- Surgical procedure
All surgeries were performed under local anesthesia 
(4% articaine with 1:100.000 adrenalin [Inibsa®, Lliça 
de Vall, Barcelona, Spain]). In all maxillary cases drills 
and osteotomes were used in combination to prepare the 
implant beds when the operator (MP) sensed that bone 
density was low.
The implants used in the present study were Mozo-Grau® 
implants, presenting a neck design with microthreads, 
treated surface, internal connection, and platform 
switching (Inhex®, Mozo-Grau, S.L. Valladolid, Spain), 
following the manufacturer’s placement instructions, 
and all patients were treated following a two-step 
procedure. After implant placement and suturing, each 
patient received 500 mg of amoxicillin (Clamoxyl®, 
GlaxoSmithKline, Madrid, Spain) three times daily for 
Inclusion criteria Exclusion criteria
- Healthy adults
- Full mouth plaque score and full mouth bleeding score  25%
- Sufficient bone height and width to place one implant with a 
minimum length of 10 mm and minimum diameter of 3.7 mm, 
without performing bone grafting procedures
- Stable occlusion and healthy periodontium
- Any patient requiring the use of bone regeneration materials for implant 
placement 
- Medical conditions contraindicating implant surgery, pregnant and nursing 
patients, smokers, patients with a history of bisphosphonate therapy, 
patients receiving head and neck chemo- or radiotherapy, severe bruxism, 
poor oral hygiene or non-collaborative patients and incomplete data 
gathering or failure to attend scheduled control appointments 
Table 1. Patient inclusion and exclusion criteria.
A B
C
D E
Fig. 1. Crestal group. A) Interdental space in the fourth quadrant. B) Implant placement at crestal level. C) Periapical X-ray view of the implant 
at the time of placement. D) Screwed definitive prosthesis. E) Periapical X-ray view of the implant after 12 months of follow-up.
Med Oral Patol Oral Cir Bucal. 2016 Jan 1;21 (1):e103-10.                                                                                                                                                       Crestal and subcrestal implant placement
e106
7 days, 600 mg of ibuprofen (Bexistar®, Laboratorio 
Bacino, Barcelona, Spain) to be taken as needed, and a 
0.12% chlorhexidine mouthwash (GUM®, John O. Butler/
Sunstar, Chicago, IL, USA) for use twice daily during two 
weeks. Gentle brushing with a chlorhexidine toothpaste 
was also recommended. Sutures were removed 8-10 
days after surgery. Prosthetic loading in the maxilla was 
carried out after 8-10 weeks following implant placement, 
and after 6-8 weeks in the case of the mandible.
The same lab technician fabricated all of the restorations. 
Crowns screwed to the Morse cone internal connection 
of the implant were prepared. All the structures were 
made of chromium-cobalt and CAD-CAM drilled 
(Bio-CAM, Mozo-Grau, S.L., Valladolid, Spain) and 
a feldspathic ceramic veneering [IPS d.SIGN, Ivoclar 
Vivadent, Schaan, Liechtenstein] was used. All screws 
were tightened with a torque of 30 Ncm according to the 
manufacturer’s specifications. The access hole of the 
screw-retained crowns was closed with a teflon pellet 
and a hybrid resin composite [Tetric-Ceram, Ivoclar 
Vivadent, Schaan, Liechtenstein]. 
- Measurements
A previously established standard protocol was used to 
compile the following data on all patients: sex, age (at 
implant placement), implant length, implant diameter, 
and brushing frequency.
Two trained clinicians (HP and DP) worked together 
to interpret the radiographs corresponding to the two 
groups in a similar manner, at the following timepoints: 
at the time of implant placement (T1) and 12 months 
after loading (T2). At each timepoint radiological 
evaluation was carried out with an XMIND intraoral 
system (Groupe Satelec-Pierre Rolland, Bordeaux, 
France) and an RVG intraoral digital receptor (Dürr 
Dental, Bietigheim-Bissingen, Germany). To reproduce 
the patient alignments, a rigid cross-arch bar was 
used with bite-registration material, and a Rinn XCP 
(Dentsply, Des Plaines, IL, USA) rod and ring were 
Fig. 2. Subcrestal group. A) Interdental space in the fourth quadrant. B) Implant placement at subcrestal level. C) Periapical X-ray view of the 
implant at the time of placement. D) Healed gingiva after three months. E) Periapical X-ray view of the implant after 12 months of follow-up. 
F) Screwed definitive prosthesis.
A B
C
E
D F
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firmly attached to the bar and placed in contact with the 
X-ray cone. The receptor was held by a slot in the bar. 
Software-based measurements were made (in mm) of 
implant marginal bone loss. For measurement purposes, 
two visible and easily localized reference points were 
selected at the implant platform. A straight line was 
traced joining the two reference points and was taken 
to represent zero height. For the determination of bone 
loss, a perpendicular line was traced mesial and distal 
to the implant from zero height to contact with the bone. 
The difference between the value recorded at the time 
of placement and after 12 months of loading was used 
to calculate bone loss mesial and distal to the implant. 
The average between mesial and distal was selected as 
the bone loss for the fixation in question, expressed as 
a positive value if the peri-implant bone was located 
coronal to the implant shoulder.
The measurement of bone loss allowed us to establish 
the exposed treated surface of the implant, which was 
defined as either the absence or presence of exposed 
surface (with the magnitude in millimeters).
The definition of implant success was based on the 
clinical and radiographic criteria described by Buser 
et al. (18): 1) absence of clinically detectable implant 
mobility; 2) absence of pain or any subjective sensation; 
3) absence of recurrent peri-implant infection; and 4) 
absence of persistent radiotransparency around the 
implant after 12 months of loading.
- Statistical analysis
In the inferential analysis we initially assessed the 
homogeneity of the crestal and subcrestal implant groups 
for the variables referred to the implant and surgical 
characteristics, based on the chi-squared test, Fisher 
exact test and nonparametric Mann-Whitney U-test. A 
nonparametric Bruner-Langer model was adopted for 
the longitudinal data, evaluating the effects of time and 
position, as well as the interaction between both, using 
nonparametric analysis of variance (ANOVA). The level 
of statistical significance was defined as 5% (α=0.05).
 
Results
A total of 26 patients were enrolled in the study. One 
patient suffered a facial dehiscence at the time of implant 
placement, and two patients did not return to complete 
the study. These three patients were excluded from the 
final data analyses. Twenty-three patients (8 males and 
15 females) with a mean age of 49.8±11.6 years (range 
28-75 years) were included in the final data analyses. The 
patient demographic characteristics are shown in table 
2. The 23 implants corresponded to 10 crestal implants 
(group A) and 13 subcrestal implants (group B).
Table 3 shows the mesial and distal bone measurements of 
the crestal and subcrestal implants at the two timepoints 
considered (T1 and T2). Following implant placement 
(T1), the mean bone position with respect to the implant 
platform was 0.0 mm in group A versus 2.16±0.88 mm 
in group B. After 12 months of follow-up (T2), the mean 
bone positions were -0.06±1.11 mm and 0.95±1.50 mm, 
respectively – this representing a bone loss of 0.06±1.11 
mm in the case of the crestal implants and of 1.22±1.06 
mm in the case of the subcrestal implants (p=0.014)
(Table 4). The crestal implants showed no significant 
variation from T1 to T2 (p=0.889), in contrast to the 
subcrestal implants (p=0.006). At T1 the differences in 
mean dimension between the two groups was significant 
(p<0.001), though by T2 the situation was seen to have 
homogenized (p=0.131) (Table 4 and Fig. 3).
Six implants in group A maintained peri-implant bone 
at the level of the implant platform, while 8 implants in 
group B presented a peri-implant bone level an average 
of 1.96 mm (range 0.54-3.80 mm) above the platform. 
Therefore, 4 crestal and 5 subcrestal implants presented 
peri-implant bone levels below the platform, leaving a 
mean exposed treated surface of 1.13 mm (range 0.65 
mm - 2 mm) and 0.57 mm (range 0.25 mm- 1.05 mm), 
respectively. The implant osseointegration success rate 
at 12 months was 100% in both groups.
Total
(n=23) 
Crestal 
(n=10) 
Subcrestal
(n=13) 
Age 49.8±11.6 years (range 28-75 years)
Sex (n) 8 males – 15 females 
Brushing frequency 1-2 times a day (85.7%) and 3 times per day (14.3%) 
Position (n)
Maxilla 13 8 5 
Mandible 10 2 8 
Location (n)
Anterior 1 0 1 
Premolar 7 5 2 
Molar 15 5 10 
Implant diameter (n)
3.7 3 0 3 
4.2 11 5 6 
5.0 9 5 4 
Implant length (n)
10 10 4 6 
11.5 8 4 4 
13 5 2 3 
Table 2. Patient demographic data.
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Discussion
The purpose of this study was to evaluate and compare 
the marginal bone loss and success of crestal and 
subcrestal implants rehabilitated with single crowns. 
Research involving implants placed subcrestally 
mainly comprise studies in animals (19-22), with fewer 
retrospective studies in humans (3,4,23,24). Only one 
prospective study has been found in the literature (25), 
involving a short follow-up of four months. Despite its 
reduced sample size of 23 patients and 23 implants and 
a short duration of follow-up (12 months), the present 
study aimed to contribute to evaluation and comparison 
of the marginal bone loss and success of implants 
placed at crestal and subcrestal level and rehabilitated 
Crestal Subcrestal
M D R M D R 
Baseline (T1) 0 ± 0 0 ± 0 0 to 0 2.48±1.29 1.85±0.53 3.6 to 1 
12 months (T2) 0.13±1.51 -0.25±0.84 0 to -2 1.04±1.88 0.86±1.39 3,8 to -1 
Mean (T2 – T1) 0.13±1.51 -0.25±0.84 -1.44±1.17 -0.99±1.29 
Table 3. Mesial and distal bone measurements of the crestal and subcrestal implants at timepoints T1 and 
T2. The values are expressed in mm.
M=mesial, D=distal, R=range.
Crestal (mean M – D) Subcrestal (mean M – D) p-value
Baseline (T1) 0 ± 0* 2.16 ± 0.86*¥ p<0.001*
12 months (T2) -0.06 ± 1.11 0.95 ± 1.50¥ p=0.131 
Mean (T2 – T1) -0.06 ± 1.11 1.22 ± 1.06* p=0.014* 
p-value p=0.889 p=0.006¥
Table 4. Mean bone measurements corresponding to the two study groups.
M=mesial, D=distal.
*¥ statistically significant differences p<0.05.
Fig. 3. Evolution of the bone crest in the two groups at the different study timepoints.
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with a single crown. The 23 consecutive patients were 
selected using strict, uniform criteria, and were treated 
by the same team of professionals using exactly the 
same procedures.
In the present study, peri-implant marginal bone loss 
was assessed from parallelized periapical radiographs, 
and was found to be 0.06±1.11 mm on average in group 
A versus 1.22±1.06 mm in group B, after 12 months 
of follow-up. These results are consistent with those 
obtained in other studies in humans (3,4,23-25), where 
the bone loss associated to implants placed at crestal 
and subcrestal level ranged from 0.5-1.5 mm and 0.08-
1.78 mm, respectively. Albrektsson et al. (26) accepted 
1 mm of peri-implant bone loss during the first year of 
function, followed by an annual loss of under 0.2 mm 
after the first year in service as criteria for implant 
success. This re-establishment of biological width may 
occur as result of micromovements at the implant–
abutment interface (27), or may be due to bacterial 
migration and colonization of the microgap on a screw-
retained abutment (28). For this reason, some authors 
(9,11-14) consider that implant placement at subcrestal 
level may be deleterious for the maintenance of peri-
implant bone, since it implies that the microgap must 
lie below the peri-implant bone crest, which induces 
localized chronic inflammation (11). Piattelli et al. 
(16) histologically evaluated bone response associated 
to different microgap locations on the alveolar crest 
(implants inserted 1-2 mm above the alveolar crest, 
implants inserted at the level of the alveolar crest, and 
implants inserted 1-1.5 mm below the alveolar crest). 
They found that if the microgap was moved coronally 
away from the alveolar crest, minimum bone loss and 
minimum inflammatory infiltration occurred.
This problem could be resolved with the introduction 
of the Morse taper internal connections (17,29), another 
recent review (30) concluded that, no implant system 
can currently provide a complete seal, occurring 
bacterial leakage irrespective of the type of connection. 
It also concluded that there is no evidence on the 
clinical significance of this microbial leakage. The 
Morse taper internal connection could reduce leakage 
to physiological and tolerable levels, which clinically 
constitutes success.
In our study, although crestal implant bone loss was 
smaller, the peri-implant bone starting point caused the 
implants to present a greater exposed treated surface 
(mean 1.13 mm) than in the case of the implants that 
had been placed at subcrestal level (mean 0.57 mm). 
Given that exposed treated surface of the implant could 
lead to complications in the peri-implant health (5), we 
suggest that subcrestal placement of the implants was 
found to be favorable, since peri-implant bone remained 
above the level of the implant platform or bone loss was 
minimal after 12 months of follow-up. From the clinical 
perspective, this could allow the maintenance of peri-
implant bone for a longer period of follow-up, thereby 
counteracting the physiological bone remodeling 
observed over time, 
The implant osseointegration success rate at 12 months 
was 100% in both of our groups. We found few studies 
in humans (3,4,23-25), though with high success rates 
(100% in most cases). Only Koh et al. (25) reported 
one failure, resulting in a success rate of 95.8%, though 
the authors do not indicate whether the single failure 
corresponded to implant placement in the crestal or 
subcrestal position.
Human clinical studies involving longer follow-up 
periods and larger sample sizes are needed to determine 
the behavior of peri-implant bone in implants placed 
at subcrestal level, and to establish the effect of oral 
exposure of the treated surface of the implant. Within 
the limits of this prospective study, it could be suggested 
that subcrestal implants result in greater bone loss. 
However, from the clinical perspective these implants 
maintained peri-implant bone levels above the implant 
platform after 12 months of follow-up, which could 
compensate physiological bone remodeling.
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